Express News | NYSE Order Imbalance 55522.0 Shares on Buy Side
Zoetis To Go Ex-Dividend On July 18th, 2024 With 0.432 USD Dividend Per Share
May 23rd - $Zoetis(ZTS.US)$ is trading ex-dividend on July 18th, 2024. Shareholders of record on July 18th, 2024 will receive 0.432 USD dividend per share on September 4th, 2024. The ex-dividend d
Zoetis Keeps Quarterly Dividend at $0.432 a Share, Payable Sept. 4 to Shareholders of Record July 18
05:01 PM EDT, 05/22/2024 (MT Newswires) -- Zoetis Keeps Quarterly Dividend at $0.432 a Share, Payable Sept. 4 to Shareholders of Record July 18 Price: 171.00, Change: -1.05, Percent Change: -0.61
Zoetis Declares $0.432 Dividend
Press Release: Zoetis Declares Third Quarter 2024 Dividend
Zoetis Declares Third Quarter 2024 Dividend PARSIPPANY, N.J.--(BUSINESS WIRE)--May 22, 2024-- The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.432 per share for the thi
Express News | NYSE Order Imbalance 79355.0 Shares on Sell Side
Here's How Much $100 Invested In Zoetis 10 Years Ago Would Be Worth Today
Zoetis (NYSE:ZTS) has outperformed the market over the past 10 years by 8.14% on an annualized basis producing an average annual return of 18.88%. Currently, Zoetis has a market capitalization of $79.
Zoetis to Participate in the William Blair 44th Annual Growth Stock Conference
PARSIPPANY, N.J.--(BUSINESS WIRE)--$ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) will participate in the William Blair 44th Annual Growth Stock Conference on Tuesday, June 4, 2024. Wetteny Joseph, Execut
Positive Long-Term Growth Forecast for Zoetis With Strong Product Adoption and Robust Franchise Performance
Zoetis (ZTS) Stock Declines Amid Concerns Over Arthritis Drugs Impacting Pets Hagens Berman
Zoetis to Participate in the Stifel 2024 Jaws and Paws Conference
PARSIPPANY, N.J.--(BUSINESS WIRE)--$ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) will participate in the Stifel 2024 Jaws and Paws Conference on Wednesday, May 29, 2024. Kristin Peck, Chief Executive Off
Zoetis Named a Top Company for DE&I by Fair360 (Formerly DiversityInc.)
Zoetis Inc. (NYSE:ZTS) has been named to Fair360's Top 50 Companies list for the first time, underscoring the company's progress and sustained commitment to advancing Diversity, Equity and Inclusion (DE&I). Zoetis is the only animal health company included in this year's Top 50 rankings.
Global Bovine Respiratory Disease Treatment Strategic Business Report 2024-2030 Featuring Bayer, Bimeda, Boehringer Ingelheim, Ceva Sante Animale, Elanco, Merck, Vetoquinol, Virbac, & Zoetis
U.S. Pledges Nearly $200M to Prevent Bird Flu Spread on Dairy Farms
Phibro Animal Health Corporation (NASDAQ:PAHC) Q3 2024 Earnings Call Transcript
Zoetis Price Target Cut to $225.00/Share From $230.00 by HSBC
Zoetis Price Target Cut to $225.00/Share From $230.00 by HSBC
Zoetis Is Maintained at Buy by HSBC
Zoetis Is Maintained at Buy by HSBC
HSBC: Maintaining the Zoetis (ZTS.US) rating, adjusted from buy to buy rating, and adjusted the target price from $230.00 to $225.00.
HSBC: Maintaining the Zoetis (ZTS.US) rating, adjusted from buy to buy rating, and adjusted the target price from $230.00 to $225.00.
HSBC Maintains Buy on Zoetis, Lowers Price Target to $225
HSBC analyst Morten Herholdt maintains Zoetis (NYSE:ZTS) with a Buy and lowers the price target from $230 to $225.
HSBC Adjusts Price Target on Zoetis to $225 From $230
Zoetis (ZTS) has an average rating of outperform and price targets ranging from $170 to $248, according to analysts polled by Capital IQ.
No Data